Business Wire

Rerouting Alone Could Cost Airlines $8 Billion This Summer, New i6 Group Data Shows

12.5.2026 10:00:00 CEST | Business Wire | Press Release

Share

Airlines flying European long-haul routes are facing a fuel cost penalty that could exceed $8 billion between May and August 2026, according to a new operational data report released today by i6 Group, a global leader in integrated aviation fuel management technology.

The report, “Middle East Conflict: Summer 2026 Outlook,” draws on real fueling transactions captured at nearly 300 airports worldwide by i6's Fusion6 platform and provides insight into the costs of the conflict so far and how it might impact summer travel, based on actual fuel supply and into-plane uplift data.

Key Findings

  • $5.6 billion – $8.4 billion: Projected industry-wide rerouting fuel cost, May–August 2026
  • 62.2%: Increase in European airport fuel book stocks (April 2026 vs. April 2025)
  • 415,373 tons: Additional CO2 generated monthly from rerouting in the i6 network alone, or the equivalent of nearly 6,000 extra London–New York round-trip flights per month

"The data captures what airlines are paying to fly around closed Middle East airspace and how operators are adapting in response," said Alex Mattos, CEO and co-founder of i6 Group. "Fuel is aviation's largest variable cost and has long been its least visible. Real-time fuel data is now critical infrastructure for the industry."

The Summer Squeeze

Since the restrictions on Middle East airspace began on February 28, 2026, airlines operating Europe-to-Asia and Europe-to-East-Africa corridors have flown longer routes around the conflict zone. Every long-haul departure now carries additional fuel to cover the detour, adding structural cost to every flight.

In the i6 network alone, the penalty currently runs at approximately $131 million per month. Scaled industry-wide, the four-month summer total could exceed $8.4 billion as flight frequencies and load factors peak through July and August.

European Fuel Reserves up 62%

The report also documents a sharp shift in fuel inventory behavior at European airports. Average book stock across 61 airports rose 62.2% in April 2026 compared to April 2025, with supply exceeding demand by 17%, up from 6% in the same period last year.

The buildup reflects a defensive hedge against further disruption to Strait of Hormuz supply chains. Operators are delivering more fuel than airlines are consuming in preparation for a potential significant supply disruption beginning in a few weeks.

A 415,000 Ton CO2 Penalty Every Month

The longer routes airlines must fly to avoid closed Middle East airspace carry environmental costs alongside financial ones. In the i6 network alone, rerouting generates an additional 415,373 tons of CO2 every month, equivalent to nearly 6,000 additional London–New York round-trip flights. Industry-wide, the figure is estimated at 4.2 to 6.2 million tons of additional emissions monthly.

The full i6 report can be accessed via the company’s website and includes route-level analysis, body-type splits and the complete report methodology.

Frequently Asked Questions

Why are European fuel stocks so high if fuel supplies are reportedly running short?

The elevated reserves are the crisis response. Operators are deliberately building a buffer against potential further disruption to Strait of Hormuz-dependent supply chains.

Why will the cost get worse in summer?

Three forces are converging.

  1. The per-flight penalty is already locked in on every departure.
  2. Summer is when load factors peak and airlines run 5–15% more flights in July and August.
  3. Many supply chains remain fragile, raising the risk of fuel rationing if the conflict continues.

How does i6 know all of this information?

All figures come from i6's Fusion6 platform, which tracks actual into-plane fueling transactions at nearly 300 airports globally. The industry-wide figures apply a conservative 10–15x scaling factor based on i6's approximate share of international fuel uplift volumes.

Notes to editors:

About i6 Group

Founded in 2013, i6 Group is transforming aviation fuel management with groundbreaking digital technology for airlines, fuel service providers and suppliers worldwide. i6 technology supports nearly 300 airports worldwide and is trusted by leading aviation organizations such as British Airways, JetBlue, KLM, Air Canada, Virgin Atlantic, Menzies Aviation, PrimeFlight, Shell Aviation, Q8 Aviation and World Fuel. Through its comprehensive refinery-to-wingtip approach, i6 enables customers to substantially reduce costs, emissions and operational complexity, driving the aviation industry toward a smarter and greener future.

Visit i6.io to learn more.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260512588108/en/

Contacts

Media Contact:
Sarah Mattina
sarah@mattinamediagroup.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 12:00:00 CEST | Press Release

Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission

KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 12:00:00 CEST | Press Release

KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige

HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press Release

HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612936893/en/ HUI (HUI:VSE) merges traditional and crypto finance: commences continuous trading in Vienna with leading market maker and announces impending token listing on major global exchange Emmanuelle Deba

Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press Release

India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of its farming population. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202606151544

Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press Release

Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discovery teams to accelerate decision-making, streamline workflows, and advance programs more efficiently from hit identification through lead optimization. "Drug discovery increasingly requires seamless integration between chemistry and biology," said Michael Dabrowski, Chief Executive Officer of Pelago Bioscience. "By bringing RG Discovery

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye